Autologous Alpha-DC1-TBVA vaccine | m-entrepreneurship.com

Product Name :
Autologous Alpha-DC1-TBVA vaccine

Search keywords :
DC1

drugId :
null

Target Vo:
Not applicable

Target Vo Short Name :
Not applicable

Moa_Name:
Immunostimulants

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Pittsburgh

Active Company_Name :
University Of Pittsburgh

Active Indication_Name:
Carcinoma, Renal Cell

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
NeuN Antibody
Bak Antibody (YA592)
CXCL5 Antibody: CXCL5 Antibody is an unconjugated, approximately 8/9 kDa, rabbit-derived, anti-CXCL5 polyclonal antibody. CXCL5 Antibody can be used for: ELISA, IHC-P, IHC-F, IF expriments in rat, and predicted: mouse background without labeling.

Author: Betaine hydrochloride

Related Posts